A normal genetic variation modulates synaptic MMP ‐9 protein levels and the severity of schizophrenia symptoms-Reference-Cited by-同舟云学术

A normal genetic variation modulates synaptic MMP ‐9 protein levels and the severity of schizophrenia symptoms

Published:2017-06-16 Issue:8 Volume:9 Page:1100-1116
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Lepeta Katarzyna¹,Purzycka Katarzyna J²,Pachulska‐Wieczorek Katarzyna²,Mitjans Marina³,Begemann Martin³,Vafadari Behnam¹,Bijata Krystian⁴,Adamiak Ryszard W²,Ehrenreich Hannelore³,Dziembowska Magdalena¹⁵,Kaczmarek Leszek¹^ORCID

Affiliation:

1. Department of Molecular and Cellular Neurobiology Nencki Institute of Experimental Biology Polish Academy of Sciences Warsaw Poland

2. Department of RNA Structure and Function Institute of Bioorganic Chemistry, Polish Academy of Sciences Poznan Poland‡

3. Clinical Neuroscience Max Planck Institute of Experimental Medicine DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB) Göttingen Germany

4. Institute of Biochemistry and Biophysics Polish Academy of Sciences Laboratory of RNA Biology and Functional Genomics Warsaw Poland

5. Laboratory of Molecular Basis of Synaptic Plasticity Centre of New Technologies University of Warsaw Warsaw Poland

Funder

Fundacja na rzecz Nauki Polskiej

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201707723

Reference74 articles.

1. Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications